コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ressed miRNAs in human cancers obtained from microarray data.
2 as validated by using independent, published microarray data.
3 ical management of cancer in the presence of microarray data.
4 f false positives and false negatives in the microarray data.
5 heir magnitude, the first such model for SNP microarray data.
6 m gene selection to infer such networks from microarray data.
7 plicitly models the possible outliers in the microarray data.
8 t germ cell-specific expression from gonadal microarray data.
9 in an independent set of publicly available microarray data.
10 o counteract the presence of outliers in the microarray data.
11 lobal test in both simulation and a diabetes microarray data.
12 een developed to identify bimodal genes from microarray data.
13 ictive clinical tool using published patient microarray data.
14 oth CCNE2 and CDC6 were downregulated in the microarray data.
15 el algorithm, VIPR, for analyzing diagnostic microarray data.
16 essment of model predictions against patient microarray data.
17 reus, Saccharomyces cerevisiae and in silico microarray data.
18 performance using alternative sequencing and microarray data.
19 ultiple etiologies by exploring high quality microarray data.
20 f known relevant genes in large compendia of microarray data.
21 uency) copy-number variants (CNVs) using SNP microarray data.
22 t pair-wise synergy in simulation and cancer microarray data.
23 can also be applied to stabilize variance in microarray data.
24 designed for archiving and analyzing protein microarray data.
25 ene regulatory networks from gene expression microarray data.
26 d apply it to the integration of RNA-seq and microarray data.
27 performed for statistical assessment of the microarray data.
28 prehensive analysis report for their protein microarray data.
29 ine part of the analysis of high-dimensional microarray data.
30 fective method to estimate purities from the microarray data.
31 se when combining batches of gene expression microarray data.
32 omes reduced to low-coverage sequence and HD microarray data.
33 space, rather than in the original space of microarray data.
34 identified from the analyses of leafy spurge microarray data; (2) 3 orthologs of Arabidopsis "general
35 e, we have integrated four public expression microarray data (320 samples) from the Gene Expression O
37 ere constructed from all currently available microarray data, 90% phenotype prediction accuracy, or t
39 own to reduce overfitting noises involved in microarray data analysis and discover functional gene se
40 e have also created a pathway module for the microarray data analysis portal ArrayAnalysis.org that c
43 munohistochemistry (IHC) staining and public microarray data analysis showing that DACH1 was higher i
44 We developed an R package for resequencing microarray data analysis that integrates a novel statist
45 alysis is an invaluable tool for exploratory microarray data analysis, as it organizes the data into
46 lthough FDR control is frequently applied to microarray data analysis, gene expression is usually cor
50 optimize the strength of interactions using microarray data and an artificial neural network fitness
51 logy will facilitate re-analysis of archived microarray data and broaden the utility of the vast quan
52 chromatin immunoprecipitation sequencing and microarray data and DNase I hypersensitive site sequenci
53 al-inverse-Wishart priors based on discarded microarray data and examine the performance on synthetic
54 r from the inclusion of excessive 'noise' in microarray data and false-positives in binding data, esp
55 anscriptional responses to TDB/TDM, we mined microarray data and identified early growth response (Eg
56 nthesis in Arabidopsis thaliana, we screened microarray data and identified transcriptional upregulat
58 pL, and bcrA-like were carried out to verify microarray data and showed the same level of up- or down
59 of antibody epitope prediction from peptide microarray data and shows utility in analyzing phage dis
61 tal cancer (CRC) metastasis was suggested by microarray data and validated by the survey of 120 patie
62 numerous transfer RNAs (tRNAs) dominated the microarray data and were validated on RNA gel blots.
64 tion model used for background correction of microarray data, and modified it to formulate an error c
65 low-coverage sequence and high-density (HD) microarray data, and remained high even with a read erro
66 ds developed for bulk RNA sequencing or even microarray data, and the suitability of these methods fo
67 dicting the survival of cancer patients from microarray data, and to classification of obese and lean
69 the methods for GSA previously developed for microarray data are based on the assumption that genes w
70 ream analysis tools previously restricted to microarray data are now available for RNA-seq as well.
72 s from multiple tissues when log-transformed microarray data are used; (ii) estimation of both tumor
74 ological perspective, we used a set of yeast microarray data as a working example, to evaluate the fu
75 ely estimate absolute expression levels from microarray data, at both gene and transcript level, whic
76 Finally, reassessing previous C. pneumoniae microarray data based on codon content, we found that up
77 r 12 candidate transcripts selected from the microarray data based upon fold change and biological re
78 component analysis and k-means clustering of microarray data, because our traditional cardiac and ser
79 athway analysis strategy comparing miRNA and microarray data between three mouse models and human don
80 f our approach on real world gene expression microarray data by applying it to existing data from amy
81 istical methods that have been developed for microarray data can be applied to RNA-Seq data, they are
82 t feature selection approaches developed for microarray data cannot handle multivariate temporal data
86 entification of differential exon use in the microarray data, clustering of exon inclusion/exclusion
88 ignificantly differentially expressed in the microarray data collected under the differing conditions
89 thods that are applied in biology to analyze microarray data, concerns regarding the compatibility of
94 ed to identify over-represented processes in microarray data derived from various disease states.
95 serum assays, including 2-way comparison of microarray data, did not lead to the identification of a
96 hidden within multilayered immunosignaturing microarray data due to its fundamental mathematical prop
97 elation coefficients between the RNA-Seq and microarray data each exceeded 0.80, with 66%~68% overlap
98 e regulatory network from publicly available microarray data, employing steps to enrich for physiolog
103 pplied association mining on a set of glycan microarray data for 211 influenza viruses from five host
106 quencing data and Affymetrix gene expression microarray data for 30 breast cancer cell lines represen
108 the RT-qPCR validation were in line with the microarray data for both miRNAs, and statistically signi
110 = 84), ELISAs of blood/BM sera (n = 41), and microarray data for mRNA levels (n = 261) were performed
111 port detailed structural analysis and glycan microarray data for recombinant hemagglutinins from A(H6
113 n RBPs and RIP-ChIP (RNP immunoprecipitation-microarray) data for 69 yeast RBPs to construct a networ
114 proteins involved in lamination, we utilized microarray data from 13 subtypes to identify differentia
115 pse-free survival (RFS) were evaluated using microarray data from 148 patients with stage I lung aden
121 tern blot, and immunofluorescence), analyzed microarray data from 99 patients with IPF and 43 control
122 iochemical interactions, our method utilizes microarray data from a group of mutants for its construc
123 demonstrate how mining publically available microarray data from a range of skin disorders can eluci
124 To this end, we performed a meta-analysis of microarray data from a variety of cytokinin-treated samp
125 dules and schizophrenia was replicated using microarray data from an independent tissue collection.
132 cell-specific patterns of gene expression in microarray data from mammalian gonads, specifically duri
135 istent with these findings, meta-analysis of microarray data from over 4,000 breast cancer patients r
136 deletions and uniparental disomy) using SNP microarray data from over 50,000 subjects recruited for
137 g glucose through the use of gene expression microarray data from peripheral blood samples of partici
138 ighted gene coexpression network analysis on microarray data from singing zebra finches to discover g
143 to generate Illumina RNA-seq and Affymetrix microarray data from the same liver samples of rats expo
144 oinformatic analysis was performed using DNA microarray data from two experimental formats: (1) ventr
145 ChIP-sequencing results with gene expression microarray data from unloaded muscle to map several dire
148 comprehensively analyzed RNA sequencing and microarray data generated by the Immunological Genome Pr
149 ful analytical tool using publicly available microarray data generated exclusively from Arabidopsis t
150 s to compare parallel paired-end RNA-Seq and microarray data generated on 5-azadeoxy-cytidine (5-Aza)
151 ed cytosine (5C), 5mC and 5hmC from Infinium microarray data given the signal intensities from the ox
154 he existing methods for analyzing diagnostic microarray data has the capacity to specifically identif
158 n silico analysis exploiting mNK cell subset microarray data, highlighting various genes and microRNA
159 Additionally, FungiDB contains cell cycle microarray data, hyphal growth RNA-sequence data and yea
162 chain reaction, and motifADE analysis of the microarray data identified potential FK506-mediated path
165 a in various primary tumors, gene expression microarray data in over 1000 cancer cell lines and prote
167 a diverse collection of PDAC gene expression microarray data, including data from primary tumor, meta
173 s was determined by FACS analysis.Affymetrix microarray data indicated that NuMA was overexpressed in
176 antly impacted in a given condition based on microarray data is a crucial step in current life scienc
178 he majority of the valuable original protein microarray data is still not publically accessible.
180 der to reduce the impact of batch effects on microarray data, Johnson, Rabinovic, and Li developed Co
181 is of Microarrays (SAM) or Linear Models for Microarray Data (LIMMA) for processing cDNA microarrays,
184 results also supported by Oncomine analyses, microarray data (n=2878) and genomic data from paired tu
186 ounding effects of ITH using gene expression microarray data obtained from multiple tumour regions of
191 involved in SA-induced folate accumulation, microarray data of responsive genes in Arabidopsis were
193 -small cell lung cancer (NSCLC), we analyzed microarray data on gene expression and methylation.
194 etwork construction, we generate independent microarray data on selected deletion mutants to prospect
195 s and heteroskedasticity across 19 groups of microarray data on the sign and magnitude of gene-to-gen
198 ditionally, criteria such as comparison with microarray data or a number of known polymorphic sites h
200 isease susceptibility, while gene expression microarray data provide genome-wide transcriptional prof
201 lity of our approach with both simulated and microarray data; random graphs and weighted (partial) co
202 glucuronidase) assays and publicly available microarray data revealed a differential spatio-temporal
211 d and Consensus Clustering Analysis Tool for Microarray Data (SC(2)ATmd) is a MATLAB-implemented appl
212 ost cells validates the previously published microarray data set demonstrating feed-forward control o
214 scription factor analysis was performed in a microarray data set profiled in four different brain reg
215 Thus a clinical classifier weighted with microarray data set results in significantly improved di
216 paper, we reanalyzed a zebrafish (D. rerio) microarray data set using GeneSpring and different diffe
224 tperforms classical algorithms developed for microarray data sets as well as recent approaches design
225 project uses the abundant publicly available microarray data sets combined with a suite of single-arr
226 lly expressed at significant levels in the 5 microarray data sets compared, providing new insights in
227 pport of our in vitro data, analysis of mRNA microarray data sets demonstrated that high levels of FK
228 med in silico analysis of publicly available microarray data sets from prostate or breast carcinomas.
229 including CCND2, hTERT, and GCLC Analysis of microarray data sets further demonstrated that MUC1 leve
231 ed TEAK with experimental studies to analyze microarray data sets profiling stress responses in the m
236 functional relationships between genes from microarray data sets using rule-based machine learning.
238 ces, such as the Allen Mouse Brain Atlas and microarray data sets, by providing quantitative expressi
243 Transcriptome in silico analysis of the microarray data showed major metabolomic variations in k
249 of the diffuse large B-cell lymphoma patient microarray data showed that miR-155 expression is invers
251 Systematic analysis of tissue-profiling microarray data showed that the zinc transporter ZIP12 (
253 ated clinical literature and gene expression microarray data stored in large international repositori
257 ymidine kinase genes (AtTK1a and AtTK1b) and microarray data suggest they might have redundant roles.
260 Thus repeat annotation of gene expression microarray data suggests that a complex interplay betwee
262 Lastly, semi-quantitative model analysis via microarray data superimposed onto the model with a score
265 ustom 'Ae. aegypti detox chip' and validated microarray data through RT-PCR comparing susceptible and
267 and an R function which uses DNA methylation microarray data to infer tumor subtypes with the conside
270 constructed gene co-expression networks from microarray data to study large-scale transcriptional pat
271 nomes pathway enrichment cluster analyses of microarray data using wild-type and c-Jun-deleted macrop
276 ng independent normal data and one involving microarray data), we show that the proposed method, when
279 Arabidopsis thaliana) homologs and available microarray data, we identified 60 candidate genes for co
281 correlation of chemical data and phylogenic microarray data, we identified several bacteria that cou
284 gene expression analysis was performed, and microarray data were assessed by Ingenuity Pathways Anal
286 n the present study, the whole transcriptome microarray data were generated from peripheral blood mon
287 signed for DEG identification in RNA-Seq and microarray data, were applied to compare the cross-platf
289 study the rewiring of gene networks through microarray data, which is becoming an important compleme
290 r mechanisms, we analyzed publicly available microarray data, which revealed a developmentally coordi
292 from this work and the predictions based on microarray data will help explore novel metabolic proces
293 network-type analyses along with time series microarray data will lead to advancements in our underst
294 e algorithms that reconcile case-control DNA microarray data with a molecular interaction network by
295 amined the behaviors of different methods to microarray data with different properties, and whether t
298 We investigate the impact of augmenting microarray data with semantic relations automatically ex
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。